Jeremy Friedberg

LAVVAN

Reimagining the cannabinoid production process to deliver high-quality, reliably sourced and cost-competitive cannabinoid ingredients LAVVAN produces a range of natural cannabinoid ingredients using its advanced cellular agriculture platform which supplies cannabinoids with unparalleled purity, consistency, potency and sustainability to serve a range of industries including health, beauty, food and beverage and pharmaceuticals. Nearly from inception, LAVVAN is led by one of the most influential, respected and pioneering teams in the global cannabis industry. After the $2.5 billion purchase of MedReleaf Corp. – a company that from 2014 to 2018 was one of the largest legal producers of cannabinoids in the world – the team dedicated itself to once again revolutionizing the industry that it helped to birth, by bringing to it a level of quality, reliability and sustainability that global brands, manufacturers and suppliers can depend on.